Skip to content

Effect of esticketamine combined with propofol in painless gastroenteroscopy

Effect of esticketamine combined with propofol in painless gastroenteroscopy

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063714
Enrollment
Unknown
Registered
2022-09-15
Start date
2022-09-19
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

painless gastrointestinal endoscopy

Interventions

Group 1 :esketamine

Sponsors

The Third People's Hospital of Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. With the consent of the patient or family members and signed informed consent; 2. Patients undergoing painless gastroenteroscopy; 3. Age 18-65 years old, no gender restriction, American Society of Anesthesiologists (ASA) classification I- Class II.

Exclusion criteria

Exclusion criteria: 1. Combined with severe cardiovascular system, respiratory system, liver and kidney function damage, coagulation dysfunction and other diseases; 2. Combined with mental diseases, long-term use of psychotropic drugs and analgesics; 3. Previous history of anesthesia allergy, abnormal anesthesia resuscitation history, difficult airway, morbidly obese patients.

Design outcomes

Primary

MeasureTime frame
heart rate;blood pressure;blood oxygen saturation;induction time;recovery time;

Secondary

MeasureTime frame
Adverse reactions;

Countries

China

Contacts

Public ContactQiang Fu

The Third People's Hospital of Chengdu

164389163@qq.com+86 19950261755

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026